A detailed history of Bessemer Group Inc transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Bessemer Group Inc holds 615 shares of MRVI stock, worth $3,456. This represents 0.0% of its overall portfolio holdings.

Number of Shares
615
Holding current value
$3,456
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$6.84 - $9.73 $4,206 - $5,983
615 New
615 $5,000
Q4 2022

Feb 13, 2023

SELL
$12.5 - $24.78 $343,837 - $681,623
-27,507 Reduced 99.91%
24 $0
Q3 2022

Nov 09, 2022

SELL
$20.6 - $30.37 $67,938 - $100,160
-3,298 Reduced 10.7%
27,531 $703,000
Q1 2022

May 12, 2022

SELL
$24.46 - $40.92 $38,206 - $63,917
-1,562 Reduced 4.82%
30,829 $1.09 Million
Q4 2021

Jan 27, 2022

BUY
$35.0 - $45.94 $425,915 - $559,043
12,169 Added 60.18%
32,391 $1.36 Million
Q3 2021

Nov 12, 2021

BUY
$36.8 - $60.62 $377,126 - $621,233
10,248 Added 102.75%
20,222 $992,000
Q2 2021

Aug 06, 2021

BUY
$32.46 - $45.0 $75,566 - $104,760
2,328 Added 30.45%
9,974 $416,000
Q1 2021

May 13, 2021

BUY
$25.8 - $38.49 $197,266 - $294,294
7,646 New
7,646 $272,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $739M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Bessemer Group Inc Portfolio

Follow Bessemer Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bessemer Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bessemer Group Inc with notifications on news.